Immunosuppressive treatment using tacrolimus promotes pregnancy outcome in infertile women with repeated implantation failures.
Koji NakagawaJoanne Kwak-KimKeiji KurodaRikikazu SugiyamaKoushi YamaguchiPublished in: American journal of reproductive immunology (New York, N.Y. : 1989) (2017)
We confirm our previous report that Th1/Th2 ratio can predict ART outcomes in patients with RIF and immunosuppressant treatment with tacrolimus, and peripheral blood Th1 cell levels were negatively correlated with pregnancy outcome.